Literature DB >> 3370840

The distinction of bone and liver isoenzymes of alkaline phosphatase in serum using a monoclonal antibody.

R N Seabrook1, E M Bailyes, C P Price, K Siddle, J P Luzio.   

Abstract

Out of 31 mouse monoclonal antibodies to human liver and bone ALP, one antibody coded BAP 1/9, showing a preference for binding the bone isoenzyme, and one antibody coded LAP 1/5, showing no preference, were selected to study binding of the serum forms of ALP. Using a plate capture assay format BAP 1/9 showed a 1.8-fold preference for binding purified bone versus liver ALP in the presence of 10% ALP-free serum compared with 2.1- to 2.25-fold preference in buffered salt solution. BAP 1/9 showed a preference for binding ALP from serum samples containing predominantly bone ALP compared to those containing predominantly liver ALP. Using predefined mixtures of serum forms of bone and liver ALP a linear relationship between ALP bound to BAP 1/9 and the fraction of bone ALP was obtained.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370840     DOI: 10.1016/0009-8981(88)90332-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Monoclonal antibody against human bone alkaline phosphatase.

Authors:  K Masuhara; R Yoshikawa; K Takaoka; K Ono; D C Morris; H C Anderson
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

2.  Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality.

Authors:  Rebecca Filipowicz; Tom Greene; Guo Wei; Alfred K Cheung; Kalani L Raphael; Bradley C Baird; Srinivasan Beddhu
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

3.  Detection of bone-type alkaline phosphatase by monoclonal antibodies reacting with human osteosarcoma-associated antigen.

Authors:  S Nagoya; T Uede; T Wada; S Ishii; S Yamawaki; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1991-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.